The Billon 2025 paper (PMID 41421047) is the citation that anchors the route question: SLU-PP-915 was developed because SLU-PP-332 "lacks oral bioavailability." If the parent compound does not absorb orally, oral capsules and tablets are unlikely to produce the systemic ERR agonism seen in mice
Corticosteroid injections can impair tendon healing, working against the peptides effects
Common dosing protocols range from 250 to 500 mcg once or twice daily , administered either subcutaneously or intramuscularly
In the present study, supplementation with vitamin B12 did not significantly improve the markers of glucose metabolism
Understanding the dosing differences between tirzepatide and semaglutide is important if you are considering a switch
It is built strictly as an informational comparison, not a shopping guide or a ranking by price, since none of these compounds are FDA-approved consumer products sold at a fixed retail cost